Literature DB >> 8875757

Hyperthyroidism caused by an ectopic TSH-secreting pituitary tumor.

D S Cooper1, B M Wenig.   

Abstract

A woman developed what appeared to be typical Graves' disease in 1965 at the age of 45 years. After 9 years of antithyroid drug therapy, she was treated with radioiodine. Ten years later (1985) she developed postablative hypothyroidism. Despite replacement doses of thyroxine that resulted in thyroid hormone levels that were in the hyperthyroid range, TSH levels remained elevated. Initial biochemical studies, including a high alpha-subunit to TSH ratio, suggested a pituitary TSH-secreting tumor, but a CT scan of the sella turcica was normal. In 1994, while undergoing an otolaryngologic examination, the patient was found to have a nasopharyngeal mass lesion, which was ultimately shown histologically and immunohistochemically to be an ectopic pituitary tumor. Resection of the mass restored TSH and alpha-subunit levels to normal. This patient probably represents the first ectopic TSH-secreting pituitary tumor to be reported.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8875757     DOI: 10.1089/thy.1996.6.337

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  10 in total

Review 1.  Medical management of thyrotropin-secreting pituitary adenomas.

Authors:  Paolo Beck-Peccoz; Luca Persani
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

2.  Ectopic TSH-secreting Pituitary Adenoma in Nasopharyngeal Region.

Authors:  F P Altay; M Kulaksızoğlu; S M Fenkci; N Yalçın; E Sağtaş
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Oct-Dec       Impact factor: 1.104

Review 3.  Clinical and radiological presentation of parasellar ectopic pituitary adenomas: case series and systematic review of the literature.

Authors:  C Campana; F Nista; L Castelletti; M Caputo; E Lavezzi; P Marzullo; A Ferrero; G Gaggero; F R Canevari; D C Rossi; G Zona; A Lania; D Ferone; F Gatto
Journal:  J Endocrinol Invest       Date:  2022-02-11       Impact factor: 5.467

4.  Nasally located ectopic ACTH-secreting pituitary adenoma (EAPA) causing Nelson's syndrome: diagnostic challenges.

Authors:  K Gurazada; A Ihuoma; M Galloway; N Dorward; T Wilhelm; B Khoo; P M G Bouloux
Journal:  Pituitary       Date:  2014-10       Impact factor: 4.107

5.  Secondary Hyperthyroidism due to an Ectopic Thyrotropin-Secreting Neuroendocrine Pituitary Tumor: A Case Report.

Authors:  Christian Trummer; Hannes Reiher; Verena Theiler-Schwetz; Marlene Pandis; Christian Gstettner; Peter Potzinger; Tilman Keck; Thomas R Pieber; Sigurd Lax; Johannes Haybaeck; Vinzenz Stepan; Stefan Pilz
Journal:  Eur Thyroid J       Date:  2020-01-21

6.  Ectopic TSH-secreting pituitary tumor: a case report and review of prior cases.

Authors:  Mingqiang Song; Haijing Wang; Li Song; Haiye Tian; Quanxu Ge; Jun Li; Yan Zhu; Jizhou Li; Runzhen Zhao; Hong-Long Ji
Journal:  BMC Cancer       Date:  2014-07-28       Impact factor: 4.430

Review 7.  Progress in the Pathogenesis, Diagnosis, and Treatment of TSH-Secreting Pituitary Neuroendocrine Tumor.

Authors:  Peiqiong Luo; Lin Zhang; Lidan Yang; Zhenmei An; Huiwen Tan
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-27       Impact factor: 5.555

Review 8.  Case Report and Literature Review: Ectopic Thyrotropin-Secreting Pituitary Adenoma in the Suprasellar Region.

Authors:  Xiaoxu Li; Binghao Zhao; Bo Hou; Jing Wang; Jianyu Zhu; Yong Yao; Xiaolan Lian
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-11       Impact factor: 5.555

Review 9.  A patient with an ectopic sphenoid bone TSH secretory adenoma: Case report and review of the literature.

Authors:  Shejil Kumar; Cun An Phang; Huajing Ni; Terrence Diamond
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-08       Impact factor: 6.055

10.  Ectopic thyrotropin secreting pituitary adenoma concomitant with papillary thyroid carcinoma: Case report.

Authors:  Jing Yang; Shu Liu; Zhe Yang; Yin Bing Shi
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.